{"entity":{"type":"insider","cik":"0001346064","url":"/insider/0001346064","json_url":"/insider/0001346064.json","name":"Sandercock Brett","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":143,"n_filings":133,"first":"2006-06-02","last":"2026-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Sandercock Brett","source":"filing","n_filings":133,"first_seen":"2006-06-02","last_seen":"2026-04-03"}],"transactions":[{"id":5781066,"accession":"0000943819-26-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000943819-26-000020","line_url":"/filing/0000943819-26-000020#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":224.31,"price_display":"224.31","price_state":"stated","total_value":224310.0,"total_display":"224,310.00","total_whole":"224,310","shares_owned_after":83495.0,"shares_owned_after_display":"83,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider"},{"id":5955514,"accession":"0000943819-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000943819-26-000013","line_url":"/filing/0000943819-26-000013#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":254.3,"price_display":"254.30","price_state":"stated","total_value":254300.0,"total_display":"254,300.00","total_whole":"254,300","shares_owned_after":84495.0,"shares_owned_after_display":"84,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5901644,"accession":"0000943819-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000943819-26-000008","line_url":"/filing/0000943819-26-000008#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":257.03,"price_display":"257.03","price_state":"stated","total_value":257030.0,"total_display":"257,030.00","total_whole":"257,030","shares_owned_after":85495.0,"shares_owned_after_display":"85,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-03","scope":"insider"},{"id":5781065,"accession":"0000943819-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000943819-26-000002","line_url":"/filing/0000943819-26-000002#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":241.75,"price_display":"241.75","price_state":"stated","total_value":241750.0,"total_display":"241,750.00","total_whole":"241,750","shares_owned_after":86495.0,"shares_owned_after_display":"86,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-05","scope":"insider"},{"id":4129536,"accession":"0000943819-25-000184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000943819-25-000184","line_url":"/filing/0000943819-25-000184#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":244.16,"price_display":"244.16","price_state":"stated","total_value":244160.0,"total_display":"244,160.00","total_whole":"244,160","shares_owned_after":87495.0,"shares_owned_after_display":"87,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-02","scope":"insider"},{"id":4904789,"accession":"0000943819-25-000092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000943819-25-000092","line_url":"/filing/0000943819-25-000092#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":247.54,"price_display":"247.54","price_state":"stated","total_value":742620.0,"total_display":"742,620.00","total_whole":"742,620","shares_owned_after":85745.0,"shares_owned_after_display":"85,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-04","scope":"insider"},{"id":4043396,"accession":"0000943819-25-000084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000943819-25-000084","line_url":"/filing/0000943819-25-000084#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":274.36,"price_display":"274.36","price_state":"stated","total_value":823080.0,"total_display":"823,080.00","total_whole":"823,080","shares_owned_after":86745.0,"shares_owned_after_display":"86,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider"},{"id":4658117,"accession":"0000943819-25-000052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000943819-25-000052","line_url":"/filing/0000943819-25-000052#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":270.77,"price_display":"270.77","price_state":"stated","total_value":812310.0,"total_display":"812,310.00","total_whole":"812,310","shares_owned_after":87745.0,"shares_owned_after_display":"87,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-03","scope":"insider"},{"id":4193125,"accession":"0000943819-25-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000943819-25-000032","line_url":"/filing/0000943819-25-000032#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":281.9,"price_display":"281.90","price_state":"stated","total_value":845700.0,"total_display":"845,700.00","total_whole":"845,700","shares_owned_after":83283.0,"shares_owned_after_display":"83,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":5149622,"accession":"0000943819-25-000025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000943819-25-000025","line_url":"/filing/0000943819-25-000025#line-3","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3883.0,"shares_display":"3,883","price_per_share":256.99,"price_display":"256.99","price_state":"stated","total_value":997892.17,"total_display":"997,892.17","total_whole":"997,892","shares_owned_after":84283.0,"shares_owned_after_display":"84,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-02","scope":"insider"},{"id":5105815,"accession":"0000943819-25-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000943819-25-000011","line_url":"/filing/0000943819-25-000011#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":243.78,"price_display":"243.78","price_state":"stated","total_value":243780.0,"total_display":"243,780.00","total_whole":"243,780","shares_owned_after":85283.0,"shares_owned_after_display":"85,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-03","scope":"insider"},{"id":4753305,"accession":"0001127602-25-015607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-015607","line_url":"/filing/0001127602-25-015607#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3644.0,"shares_display":"3,644","price_per_share":244.59,"price_display":"244.59","price_state":"stated","total_value":891285.96,"total_display":"891,285.96","total_whole":"891,286","shares_owned_after":86283.0,"shares_owned_after_display":"86,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-22","filed_date":"2025-05-27","scope":"insider"},{"id":4043744,"accession":"0001127602-25-011925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-011925","line_url":"/filing/0001127602-25-011925#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":215.58,"price_display":"215.58","price_state":"stated","total_value":215580.0,"total_display":"215,580.00","total_whole":"215,580","shares_owned_after":89864.0,"shares_owned_after_display":"89,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-08","filed_date":"2025-04-10","scope":"insider"},{"id":4052736,"accession":"0001127602-25-009188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-009188","line_url":"/filing/0001127602-25-009188#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":230.36,"price_display":"230.36","price_state":"stated","total_value":230360.0,"total_display":"230,360.00","total_whole":"230,360","shares_owned_after":90864.0,"shares_owned_after_display":"90,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-11","scope":"insider"},{"id":4957074,"accession":"0001127602-25-004042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-004042","line_url":"/filing/0001127602-25-004042#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":238.98,"price_display":"238.98","price_state":"stated","total_value":238980.0,"total_display":"238,980.00","total_whole":"238,980","shares_owned_after":91864.0,"shares_owned_after_display":"91,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-11","scope":"insider"},{"id":4800991,"accession":"0001127602-25-001067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001067","line_url":"/filing/0001127602-25-001067#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":234.04,"price_display":"234.04","price_state":"stated","total_value":234040.0,"total_display":"234,040.00","total_whole":"234,040","shares_owned_after":92864.0,"shares_owned_after_display":"92,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":3069384,"accession":"0001127602-24-029095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-029095","line_url":"/filing/0001127602-24-029095#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":244.23,"price_display":"244.23","price_state":"stated","total_value":244230.0,"total_display":"244,230.00","total_whole":"244,230","shares_owned_after":93864.0,"shares_owned_after_display":"93,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-11","scope":"insider"},{"id":2173749,"accession":"0001127602-24-027030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-027030","line_url":"/filing/0001127602-24-027030#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":249.0,"price_display":"249.00","price_state":"stated","total_value":249000.0,"total_display":"249,000.00","total_whole":"249,000","shares_owned_after":94864.0,"shares_owned_after_display":"94,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":3069049,"accession":"0001127602-24-025369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-025369","line_url":"/filing/0001127602-24-025369#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":233.47,"price_display":"233.47","price_state":"stated","total_value":233470.0,"total_display":"233,470.00","total_whole":"233,470","shares_owned_after":95812.0,"shares_owned_after_display":"95,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-08","filed_date":"2024-10-09","scope":"insider"},{"id":2309363,"accession":"0001127602-24-023758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-023758","line_url":"/filing/0001127602-24-023758#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":246.42,"price_display":"246.42","price_state":"stated","total_value":246420.0,"total_display":"246,420.00","total_whole":"246,420","shares_owned_after":96812.0,"shares_owned_after_display":"96,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-10","scope":"insider"},{"id":3026121,"accession":"0001127602-24-021984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-021984","line_url":"/filing/0001127602-24-021984#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":212.16,"price_display":"212.16","price_state":"stated","total_value":212160.0,"total_display":"212,160.00","total_whole":"212,160","shares_owned_after":89056.0,"shares_owned_after_display":"89,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-08","filed_date":"2024-08-12","scope":"insider"},{"id":2262602,"accession":"0001127602-24-020248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-020248","line_url":"/filing/0001127602-24-020248#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":194.35,"price_display":"194.35","price_state":"stated","total_value":194350.0,"total_display":"194,350.00","total_whole":"194,350","shares_owned_after":90056.0,"shares_owned_after_display":"90,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-08","filed_date":"2024-07-09","scope":"insider"},{"id":2308705,"accession":"0001127602-24-018379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-018379","line_url":"/filing/0001127602-24-018379#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":209.81,"price_display":"209.81","price_state":"stated","total_value":209810.0,"total_display":"209,810.00","total_whole":"209,810","shares_owned_after":91056.0,"shares_owned_after_display":"91,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-11","scope":"insider"},{"id":2087447,"accession":"0001127602-24-014978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-014978","line_url":"/filing/0001127602-24-014978#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":211.37,"price_display":"211.37","price_state":"stated","total_value":2747810.0,"total_display":"2,747,810.00","total_whole":"2,747,810","shares_owned_after":92056.0,"shares_owned_after_display":"92,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-08","filed_date":"2024-05-10","scope":"insider"},{"id":8699996,"accession":"0001127602-23-028436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-028436","line_url":"/filing/0001127602-23-028436#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":152.6201,"price_display":"152.62","price_state":"stated","total_value":457860.3,"total_display":"457,860.30","total_whole":"457,860","shares_owned_after":92962.0,"shares_owned_after_display":"92,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider"},{"id":8432090,"accession":"0001127602-23-015482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-015482","line_url":"/filing/0001127602-23-015482#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12574.0,"shares_display":"12,574","price_per_share":233.1315,"price_display":"233.13","price_state":"stated","total_value":2931395.481,"total_display":"2,931,395.48","total_whole":"2,931,395","shares_owned_after":90942.0,"shares_owned_after_display":"90,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-12","scope":"insider"},{"id":8649631,"accession":"0001127602-23-015146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-015146","line_url":"/filing/0001127602-23-015146#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3426.0,"shares_display":"3,426","price_per_share":232.049,"price_display":"232.05","price_state":"stated","total_value":794999.874,"total_display":"794,999.87","total_whole":"795,000","shares_owned_after":103516.0,"shares_owned_after_display":"103,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-10","scope":"insider"},{"id":8320562,"accession":"0001127602-23-006460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-006460","line_url":"/filing/0001127602-23-006460#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":215.2196,"price_display":"215.22","price_state":"stated","total_value":2152196.0,"total_display":"2,152,196.00","total_whole":"2,152,196","shares_owned_after":106880.0,"shares_owned_after_display":"106,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-22","scope":"insider"},{"id":8320445,"accession":"0001127602-23-005095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-005095","line_url":"/filing/0001127602-23-005095#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":215.0,"price_display":"215.00","price_state":"stated","total_value":860000.0,"total_display":"860,000.00","total_whole":"860,000","shares_owned_after":116880.0,"shares_owned_after_display":"116,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider"},{"id":6250295,"accession":"0001127602-22-025209","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-025209","line_url":"/filing/0001127602-22-025209#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":212.0169,"price_display":"212.02","price_state":"stated","total_value":848067.6,"total_display":"848,067.60","total_whole":"848,068","shares_owned_after":106303.0,"shares_owned_after_display":"106,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-09","scope":"insider"},{"id":6773325,"accession":"0001127602-22-020860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-020860","line_url":"/filing/0001127602-22-020860#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":240.66,"price_display":"240.66","price_state":"stated","total_value":601650.0,"total_display":"601,650.00","total_whole":"601,650","shares_owned_after":106426.0,"shares_owned_after_display":"106,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-12","scope":"insider"},{"id":6886367,"accession":"0001127602-22-019773","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-22-019773","line_url":"/filing/0001127602-22-019773#line-4","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":235.0,"price_display":"235.00","price_state":"stated","total_value":1762500.0,"total_display":"1,762,500.00","total_whole":"1,762,500","shares_owned_after":106426.0,"shares_owned_after_display":"106,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-26","scope":"insider"},{"id":6270041,"accession":"0001127602-22-011914","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-011914","line_url":"/filing/0001127602-22-011914#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":247.0,"price_display":"247.00","price_state":"stated","total_value":617500.0,"total_display":"617,500.00","total_whole":"617,500","shares_owned_after":106354.0,"shares_owned_after_display":"106,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-12","scope":"insider"},{"id":6885323,"accession":"0001127602-22-009063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-009063","line_url":"/filing/0001127602-22-009063#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":241.29,"price_display":"241.29","price_state":"stated","total_value":603225.0,"total_display":"603,225.00","total_whole":"603,225","shares_owned_after":106354.0,"shares_owned_after_display":"106,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-10","filed_date":"2022-03-14","scope":"insider"},{"id":6359613,"accession":"0001127602-22-004725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-004725","line_url":"/filing/0001127602-22-004725#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":241.86,"price_display":"241.86","price_state":"stated","total_value":604650.0,"total_display":"604,650.00","total_whole":"604,650","shares_owned_after":106354.0,"shares_owned_after_display":"106,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-10","filed_date":"2022-02-14","scope":"insider"},{"id":6746267,"accession":"0001127602-22-001337","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-001337","line_url":"/filing/0001127602-22-001337#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":235.0,"price_display":"235.00","price_state":"stated","total_value":587500.0,"total_display":"587,500.00","total_whole":"587,500","shares_owned_after":106354.0,"shares_owned_after_display":"106,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-11","scope":"insider"},{"id":4217575,"accession":"0001127602-21-030901","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-030901","line_url":"/filing/0001127602-21-030901#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":264.92,"price_display":"264.92","price_state":"stated","total_value":662300.0,"total_display":"662,300.00","total_whole":"662,300","shares_owned_after":106354.0,"shares_owned_after_display":"106,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-14","scope":"insider"},{"id":4962123,"accession":"0001127602-21-028929","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-028929","line_url":"/filing/0001127602-21-028929#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":260.58,"price_display":"260.58","price_state":"stated","total_value":651450.0,"total_display":"651,450.00","total_whole":"651,450","shares_owned_after":84833.0,"shares_owned_after_display":"84,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider"},{"id":4171710,"accession":"0001127602-21-026987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-026987","line_url":"/filing/0001127602-21-026987#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":253.37,"price_display":"253.37","price_state":"stated","total_value":1266850.0,"total_display":"1,266,850.00","total_whole":"1,266,850","shares_owned_after":84786.0,"shares_owned_after_display":"84,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-12","scope":"insider"},{"id":5005055,"accession":"0001127602-21-025210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-025210","line_url":"/filing/0001127602-21-025210#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":297.33,"price_display":"297.33","price_state":"stated","total_value":1486650.0,"total_display":"1,486,650.00","total_whole":"1,486,650","shares_owned_after":87286.0,"shares_owned_after_display":"87,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-13","scope":"insider"},{"id":5510518,"accession":"0001127602-21-024177","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-21-024177","line_url":"/filing/0001127602-21-024177#line-3","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10736.0,"shares_display":"10,736","price_per_share":281.73,"price_display":"281.73","price_state":"stated","total_value":3024653.28,"total_display":"3,024,653.28","total_whole":"3,024,653","shares_owned_after":89786.0,"shares_owned_after_display":"89,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-20","filed_date":"2021-08-23","scope":"insider"},{"id":4888593,"accession":"0001127602-21-023535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-023535","line_url":"/filing/0001127602-21-023535#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":278.05,"price_display":"278.05","price_state":"stated","total_value":695125.0,"total_display":"695,125.00","total_whole":"695,125","shares_owned_after":85002.0,"shares_owned_after_display":"85,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-11","scope":"insider"},{"id":4961144,"accession":"0001127602-21-021895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-021895","line_url":"/filing/0001127602-21-021895#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":248.46,"price_display":"248.46","price_state":"stated","total_value":621150.0,"total_display":"621,150.00","total_whole":"621,150","shares_owned_after":87502.0,"shares_owned_after_display":"87,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-13","scope":"insider"},{"id":4292279,"accession":"0001127602-21-019756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-019756","line_url":"/filing/0001127602-21-019756#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":212.84,"price_display":"212.84","price_state":"stated","total_value":532100.0,"total_display":"532,100.00","total_whole":"532,100","shares_owned_after":90002.0,"shares_owned_after_display":"90,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-14","scope":"insider"},{"id":5538046,"accession":"0001127602-21-016280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-016280","line_url":"/filing/0001127602-21-016280#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":196.0,"price_display":"196.00","price_state":"stated","total_value":490000.0,"total_display":"490,000.00","total_whole":"490,000","shares_owned_after":92502.0,"shares_owned_after_display":"92,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-10","filed_date":"2021-05-11","scope":"insider"},{"id":4776738,"accession":"0001127602-21-013698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-013698","line_url":"/filing/0001127602-21-013698#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":198.47,"price_display":"198.47","price_state":"stated","total_value":496175.0,"total_display":"496,175.00","total_whole":"496,175","shares_owned_after":94922.0,"shares_owned_after_display":"94,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-13","scope":"insider"},{"id":4170260,"accession":"0001127602-21-010277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-010277","line_url":"/filing/0001127602-21-010277#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":185.0,"price_display":"185.00","price_state":"stated","total_value":462500.0,"total_display":"462,500.00","total_whole":"462,500","shares_owned_after":97422.0,"shares_owned_after_display":"97,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-11","scope":"insider"},{"id":4989059,"accession":"0001127602-21-005251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-005251","line_url":"/filing/0001127602-21-005251#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":201.37,"price_display":"201.37","price_state":"stated","total_value":503425.0,"total_display":"503,425.00","total_whole":"503,425","shares_owned_after":99922.0,"shares_owned_after_display":"99,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-11","scope":"insider"},{"id":4212260,"accession":"0001127602-21-001481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-001481","line_url":"/filing/0001127602-21-001481#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":218.7,"price_display":"218.70","price_state":"stated","total_value":546750.0,"total_display":"546,750.00","total_whole":"546,750","shares_owned_after":100600.0,"shares_owned_after_display":"100,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider"},{"id":2429709,"accession":"0001127602-20-031237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-031237","line_url":"/filing/0001127602-20-031237#line-1","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001346064","owner_name":"Sandercock Brett","owner_display_name":"Sandercock Brett","owner_url":"/insider/0001346064","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":211.06,"price_display":"211.06","price_state":"stated","total_value":527650.0,"total_display":"527,650.00","total_whole":"527,650","shares_owned_after":103100.0,"shares_owned_after_display":"103,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-14","scope":"insider"}],"collapsed":true,"next_cursor":"2020-12-10|2429709","ledger_fault":false,"count":{"value":143,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":143,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":143},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000943819","name":"RESMED INC","url":"/issuer/0000943819","role":"Officer (Chief Financial Officer)","n_filings":133,"first_seen":"2006-06-02","last_seen":"2026-04-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001346064","retrieved_at":"2026-08-24T01:58:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}